An Algorithm for Risk Assessment and Intervention of Mother to Child Transmission of Hepatitis B Virus

Calvin Q. Pan, Zhong Ping Duan, Kalyan R Bhamidimarri, Huai Bin Zou, Xiao Feng Liang, Jie Li, Myron J. Tong

Research output: Contribution to journalArticle

131 Citations (Scopus)

Abstract

Background & Aims: Despite immunoprophylaxis, mother to child transmission (MTCT) of hepatitis B virus (HBV) still occurs in infants born to hepatitis B surface antigen (HBsAg)-positive mothers. We analyzed methods of risk assessment and interventions for MTCT. Methods: We reviewed 63 articles and abstracts published from 1975-2011 that were relevant to MTCT; articles were identified using the PubMed bibliographic database. Results: Administration of HB immunoglobulin and HB vaccine to infants at birth (within 12 hours), followed by 2 additional doses of vaccines within 6-12 months, prevented approximately 95% of HBV transmission from HBsAg-positive mothers to their infants. However, HBV was still transmitted from 8%-30% of mothers with high levels of viremia. It is important to assess the risk for MTCT and identify mothers who are the best candidates for intervention. The most important risk factor is maternal level of HBV DNA >200,000 IU (10 6 copies)/mL; other factors include a positive test result for the HB e antigen, pregnancy complications such as threatened preterm labor or prolonged labor, and failure of immunoprophylaxis in prior children. Antiviral therapy during late stages of pregnancy is the most effective method to reduce transmission from mothers with high levels of viremia, but elective cesarean section might also be effective. Antepartum administration of HB immunoglobulin, giving infants a double dose of HB vaccine, or avoiding breastfeeding had no impact on MTCT. Conclusions: HBsAg-positive mothers should be assessed for risk of MTCT, and infants should receive immunoprophylaxis. Pregnant women with levels of HBV DNA >200,000 IU/mL should be considered for strategies to reduce the risk for MTCT. We propose an algorithm for risk assessment and patient management that is based on a review of the literature and the opinion of a panel of physicians with expertise in preventing MTCT.

Original languageEnglish (US)
Pages (from-to)452-459
Number of pages8
JournalClinical Gastroenterology and Hepatology
Volume10
Issue number5
DOIs
StatePublished - May 2012

Fingerprint

Hepatitis B virus
Mothers
Hepatitis B Surface Antigens
Vaccines
Viremia
Immunoglobulins
Bibliographic Databases
Hepatitis B e Antigens
Pregnancy Complications
Premature Obstetric Labor
DNA
Breast Feeding
PubMed
Cesarean Section
Antiviral Agents
Pregnant Women

Keywords

  • Intrauterine Infection
  • Perinatal Transmission
  • Pregnancy Antiviral Therapy
  • Vaccination

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

An Algorithm for Risk Assessment and Intervention of Mother to Child Transmission of Hepatitis B Virus. / Pan, Calvin Q.; Duan, Zhong Ping; Bhamidimarri, Kalyan R; Zou, Huai Bin; Liang, Xiao Feng; Li, Jie; Tong, Myron J.

In: Clinical Gastroenterology and Hepatology, Vol. 10, No. 5, 05.2012, p. 452-459.

Research output: Contribution to journalArticle

Pan, Calvin Q. ; Duan, Zhong Ping ; Bhamidimarri, Kalyan R ; Zou, Huai Bin ; Liang, Xiao Feng ; Li, Jie ; Tong, Myron J. / An Algorithm for Risk Assessment and Intervention of Mother to Child Transmission of Hepatitis B Virus. In: Clinical Gastroenterology and Hepatology. 2012 ; Vol. 10, No. 5. pp. 452-459.
@article{a7e8cfd792fa416ab0ffd43dd3505422,
title = "An Algorithm for Risk Assessment and Intervention of Mother to Child Transmission of Hepatitis B Virus",
abstract = "Background & Aims: Despite immunoprophylaxis, mother to child transmission (MTCT) of hepatitis B virus (HBV) still occurs in infants born to hepatitis B surface antigen (HBsAg)-positive mothers. We analyzed methods of risk assessment and interventions for MTCT. Methods: We reviewed 63 articles and abstracts published from 1975-2011 that were relevant to MTCT; articles were identified using the PubMed bibliographic database. Results: Administration of HB immunoglobulin and HB vaccine to infants at birth (within 12 hours), followed by 2 additional doses of vaccines within 6-12 months, prevented approximately 95{\%} of HBV transmission from HBsAg-positive mothers to their infants. However, HBV was still transmitted from 8{\%}-30{\%} of mothers with high levels of viremia. It is important to assess the risk for MTCT and identify mothers who are the best candidates for intervention. The most important risk factor is maternal level of HBV DNA >200,000 IU (10 6 copies)/mL; other factors include a positive test result for the HB e antigen, pregnancy complications such as threatened preterm labor or prolonged labor, and failure of immunoprophylaxis in prior children. Antiviral therapy during late stages of pregnancy is the most effective method to reduce transmission from mothers with high levels of viremia, but elective cesarean section might also be effective. Antepartum administration of HB immunoglobulin, giving infants a double dose of HB vaccine, or avoiding breastfeeding had no impact on MTCT. Conclusions: HBsAg-positive mothers should be assessed for risk of MTCT, and infants should receive immunoprophylaxis. Pregnant women with levels of HBV DNA >200,000 IU/mL should be considered for strategies to reduce the risk for MTCT. We propose an algorithm for risk assessment and patient management that is based on a review of the literature and the opinion of a panel of physicians with expertise in preventing MTCT.",
keywords = "Intrauterine Infection, Perinatal Transmission, Pregnancy Antiviral Therapy, Vaccination",
author = "Pan, {Calvin Q.} and Duan, {Zhong Ping} and Bhamidimarri, {Kalyan R} and Zou, {Huai Bin} and Liang, {Xiao Feng} and Jie Li and Tong, {Myron J.}",
year = "2012",
month = "5",
doi = "10.1016/j.cgh.2011.10.041",
language = "English (US)",
volume = "10",
pages = "452--459",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - An Algorithm for Risk Assessment and Intervention of Mother to Child Transmission of Hepatitis B Virus

AU - Pan, Calvin Q.

AU - Duan, Zhong Ping

AU - Bhamidimarri, Kalyan R

AU - Zou, Huai Bin

AU - Liang, Xiao Feng

AU - Li, Jie

AU - Tong, Myron J.

PY - 2012/5

Y1 - 2012/5

N2 - Background & Aims: Despite immunoprophylaxis, mother to child transmission (MTCT) of hepatitis B virus (HBV) still occurs in infants born to hepatitis B surface antigen (HBsAg)-positive mothers. We analyzed methods of risk assessment and interventions for MTCT. Methods: We reviewed 63 articles and abstracts published from 1975-2011 that were relevant to MTCT; articles were identified using the PubMed bibliographic database. Results: Administration of HB immunoglobulin and HB vaccine to infants at birth (within 12 hours), followed by 2 additional doses of vaccines within 6-12 months, prevented approximately 95% of HBV transmission from HBsAg-positive mothers to their infants. However, HBV was still transmitted from 8%-30% of mothers with high levels of viremia. It is important to assess the risk for MTCT and identify mothers who are the best candidates for intervention. The most important risk factor is maternal level of HBV DNA >200,000 IU (10 6 copies)/mL; other factors include a positive test result for the HB e antigen, pregnancy complications such as threatened preterm labor or prolonged labor, and failure of immunoprophylaxis in prior children. Antiviral therapy during late stages of pregnancy is the most effective method to reduce transmission from mothers with high levels of viremia, but elective cesarean section might also be effective. Antepartum administration of HB immunoglobulin, giving infants a double dose of HB vaccine, or avoiding breastfeeding had no impact on MTCT. Conclusions: HBsAg-positive mothers should be assessed for risk of MTCT, and infants should receive immunoprophylaxis. Pregnant women with levels of HBV DNA >200,000 IU/mL should be considered for strategies to reduce the risk for MTCT. We propose an algorithm for risk assessment and patient management that is based on a review of the literature and the opinion of a panel of physicians with expertise in preventing MTCT.

AB - Background & Aims: Despite immunoprophylaxis, mother to child transmission (MTCT) of hepatitis B virus (HBV) still occurs in infants born to hepatitis B surface antigen (HBsAg)-positive mothers. We analyzed methods of risk assessment and interventions for MTCT. Methods: We reviewed 63 articles and abstracts published from 1975-2011 that were relevant to MTCT; articles were identified using the PubMed bibliographic database. Results: Administration of HB immunoglobulin and HB vaccine to infants at birth (within 12 hours), followed by 2 additional doses of vaccines within 6-12 months, prevented approximately 95% of HBV transmission from HBsAg-positive mothers to their infants. However, HBV was still transmitted from 8%-30% of mothers with high levels of viremia. It is important to assess the risk for MTCT and identify mothers who are the best candidates for intervention. The most important risk factor is maternal level of HBV DNA >200,000 IU (10 6 copies)/mL; other factors include a positive test result for the HB e antigen, pregnancy complications such as threatened preterm labor or prolonged labor, and failure of immunoprophylaxis in prior children. Antiviral therapy during late stages of pregnancy is the most effective method to reduce transmission from mothers with high levels of viremia, but elective cesarean section might also be effective. Antepartum administration of HB immunoglobulin, giving infants a double dose of HB vaccine, or avoiding breastfeeding had no impact on MTCT. Conclusions: HBsAg-positive mothers should be assessed for risk of MTCT, and infants should receive immunoprophylaxis. Pregnant women with levels of HBV DNA >200,000 IU/mL should be considered for strategies to reduce the risk for MTCT. We propose an algorithm for risk assessment and patient management that is based on a review of the literature and the opinion of a panel of physicians with expertise in preventing MTCT.

KW - Intrauterine Infection

KW - Perinatal Transmission

KW - Pregnancy Antiviral Therapy

KW - Vaccination

UR - http://www.scopus.com/inward/record.url?scp=84862777352&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862777352&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2011.10.041

DO - 10.1016/j.cgh.2011.10.041

M3 - Article

C2 - 22079509

AN - SCOPUS:84862777352

VL - 10

SP - 452

EP - 459

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 5

ER -